PURPOSE: A proteomics approach is warranted to further elucidate the molecular steps involved in lung tumor development. We asked whether we could classify preinvasive lesions of airway epithelium according to their proteomic profile. EXPERIMENTAL DESIGN: We obtained matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiles from 10-microm sections of fresh-frozen tissue samples: 25 normal lung, 29 normal bronchial epithelium, and 20 preinvasive and 36 invasive lung tumor tissue samples from 53 patients. Proteomic profiles were calibrated, binned, and normalized before analysis. We performed class comparison, class prediction, and supervised hierarchic cluster analysis. We tested a set of discriminatory features obtained in a previously published dataset to classify this independent set of normal, preinvasive, and invasive lung tissues. RESULTS: We found a specific proteomic profile that allows an overall predictive accuracy of over 90% of normal, preinvasive, and invasive lung tissues. The proteomic profiles of these tissues were distinct from each other within a disease continuum. We trained our prediction model in a previously published dataset and tested it in a new blinded test set to reach an overall 74% accuracy in classifying tumors from normal tissues. CONCLUSIONS: We found specific patterns of protein expression of the airway epithelium that accurately classify bronchial and alveolar tissue with normal histology from preinvasive bronchial lesions and from invasive lung cancer. Although further study is needed to validate this approach and to identify biomarkers of tumor development, this is a first step toward a new proteomic characterization of the human model of lung cancer tumorigenesis.
PURPOSE: A proteomics approach is warranted to further elucidate the molecular steps involved in lung tumor development. We asked whether we could classify preinvasive lesions of airway epithelium according to their proteomic profile. EXPERIMENTAL DESIGN: We obtained matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiles from 10-microm sections of fresh-frozen tissue samples: 25 normal lung, 29 normal bronchial epithelium, and 20 preinvasive and 36 invasive lung tumor tissue samples from 53 patients. Proteomic profiles were calibrated, binned, and normalized before analysis. We performed class comparison, class prediction, and supervised hierarchic cluster analysis. We tested a set of discriminatory features obtained in a previously published dataset to classify this independent set of normal, preinvasive, and invasive lung tissues. RESULTS: We found a specific proteomic profile that allows an overall predictive accuracy of over 90% of normal, preinvasive, and invasive lung tissues. The proteomic profiles of these tissues were distinct from each other within a disease continuum. We trained our prediction model in a previously published dataset and tested it in a new blinded test set to reach an overall 74% accuracy in classifying tumors from normal tissues. CONCLUSIONS: We found specific patterns of protein expression of the airway epithelium that accurately classify bronchial and alveolar tissue with normal histology from preinvasive bronchial lesions and from invasive lung cancer. Although further study is needed to validate this approach and to identify biomarkers of tumor development, this is a first step toward a new proteomic characterization of the human model of lung cancer tumorigenesis.
Authors: Sheila A Prindiville; Tim Byers; Fred R Hirsch; Wilbur A Franklin; York E Miller; Kieu O Vu; Holly J Wolf; Anna E Barón; Kenneth R Shroyer; Chan Zeng; Tim C Kennedy; Paul A Bunn Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-10 Impact factor: 4.254
Authors: Kiyoshi Yanagisawa; Yu Shyr; Baogang J Xu; Pierre P Massion; Paul H Larsen; Bill C White; John R Roberts; Mary Edgerton; Adriana Gonzalez; Sorena Nadaf; Jason H Moore; Richard M Caprioli; David P Carbone Journal: Lancet Date: 2003-08-09 Impact factor: 79.321
Authors: Noboru Yamagata; Yu Shyr; Kiyoshi Yanagisawa; Mary Edgerton; Thao P Dang; Adriana Gonzalez; Sorena Nadaf; Paul Larsen; John R Roberts; Jonathan C Nesbitt; Roy Jensen; Shawn Levy; Jason H Moore; John D Minna; David P Carbone Journal: Clin Cancer Res Date: 2003-10-15 Impact factor: 12.531
Authors: Stefan K Maier; Hannes Hahne; Amin Moghaddas Gholami; Benjamin Balluff; Stephan Meding; Cédrik Schoene; Axel K Walch; Bernhard Kuster Journal: Mol Cell Proteomics Date: 2013-06-19 Impact factor: 5.911
Authors: Brigitte N Gomperts; Avrum Spira; Pierre P Massion; Tonya C Walser; Ignacio I Wistuba; John D Minna; Steven M Dubinett Journal: Semin Respir Crit Care Med Date: 2011-04-15 Impact factor: 3.119
Authors: Fredrick T Harris; S M Jamshedur Rahman; Mohamed Hassanein; Jun Qian; Megan D Hoeksema; Heidi Chen; Rosana Eisenberg; Pierre Chaurand; Richard M Caprioli; Masakazu Shiota; Pierre P Massion Journal: Cancer Prev Res (Phila) Date: 2014-05-12
Authors: Christine H Chung; Erin H Seeley; Heinrich Roder; Julia Grigorieva; Maxim Tsypin; Joanna Roder; Barbara A Burtness; Athanassios Argiris; Arlene A Forastiere; Jill Gilbert; Barbara Murphy; Richard M Caprioli; David P Carbone; Ezra E W Cohen Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-01-19 Impact factor: 4.254
Authors: Christy L Ventura; Roger Higdon; Laura Hohmann; Daniel Martin; Eugene Kolker; H Denny Liggitt; Shawn J Skerrett; Craig E Rubens Journal: Infect Immun Date: 2008-10-13 Impact factor: 3.441
Authors: Katrina Steiling; Aran Y Kadar; Agnes Bergerat; James Flanigon; Sriram Sridhar; Vishal Shah; Q Rushdy Ahmad; Jerome S Brody; Marc E Lenburg; Martin Steffen; Avrum Spira Journal: PLoS One Date: 2009-04-09 Impact factor: 3.240